JSPR

Jasper Therapeutics Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↓ 1/10
  • Momentum↓ 1/10
Jasper Therapeutics sales and earnings growth
JSPR Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -24.89%
  • FCF Y/Y↓ -30.47%
Jasper Therapeutics gross and profit margin trends
JSPR Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↑ 1140.10%
Jasper Therapeutics net debt vs free cash flow
JSPR Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Jasper Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗